TEST BANK LEHNE'S PHARMACOTHERAPEUT ICS FOR ADVANCED PRACTICE

TEST BANK LEHNE'S PHARMACOTHERAPEUT ICS FOR ADVANCED PRACTICE TEST BANK LEHNE'S PHARMACOTHERAPEUT ICS FOR ADVANCED PRACTICE TEST BANK LEHNE'S PHARMACOTHERAPEUT ICS FOR ADVANCED PRACTICE TEST BANK LEHNE'S PHARMACOTHERAPEUT ICS FOR ADVANCED PRACTICE Table of Contents UNIT I: INTRODUCTION 1. Prescriptive Authority 2. Rational Drug Selection and Prescription Writing 3. Promoting Positive Outcomes of Drug Therapy UNIT II: BASIC PRINCIPLES OF PHARMACOLOGY 4. Pharmacokinetics, Pharmacodynamics, and Drug Interactions 5. Adverse Drug Reactions and Medication Errors 6. Individual Variation in Drug Responses UNIT III: DRUG THERAPY ACROSS THE LIFE SPAN 7. Drug Therapy During Pregnancy and Breast-Feeding 8. Drug Therapy in Pediatric Patients 9. Drug Therapy in Geriatric Patients UNIT IV: PERIPHERAL NERVOUS SYSTEM DRUGS 10. Basic Principles of Neuropharmacology 11. Physiology of the Peripheral Nervous System 12. Muscarinic Agonists and Antagonists 13. Adrenergic Agonists 14. Adrenergic Antagonists 15. Indirect-Acting Antiadrenergic Agents UNIT V: CENTRAL NERVOUS SYSTEM DRUGS 16. Introduction to Central Nervous System Pharmacology 17. Drugs for Parkinson's Disease 18. Drugs for Alzheimer's Disease 19. Drugs for Epilepsy 20. Drugs for Muscle Spasm and Spasticity UNIT VI: DRUGS FOR PAIN 21. Local Anesthetics 22. Opioid Analgesics, Opioid Antagonists, and Nonopioid Centrally Acting Analgesics 23. Drugs for Headache UNIT VII: PSYCHOTHERAPEUTIC DRUGS 24. Antipsychotic Agents and Their Use in Schizophrenia 25. Antidepressants 26. Drugs for Bipolar Disorder 27. Sedative-Hypnotic Drugs 28. Management of Anxiety Disorders 29. Central Nervous System Stimulants and Attention-Deficit/Hyperactivity Disorder UNIT VIII: DRUG ABUSE 30. Drug Abuse I: Basic Considerations 31. Drug Abuse II: Alcohol 32. Drug Abuse III: Nicotine and Smoking 33. Drug Abuse IV: Major Drugs of Abuse Other Than Alcohol and Nicotine UNIT IX: DRUGS THAT AFFECT THE HEART, BLOOD VESSELS, BLOOD, AND BLOOD VOLUME 34. Review of Hemodynamics 35. Diuretics 36. Drugs Acting on the Renin-Angiotensin-Aldosterone System 37. Calcium Channel Blockers 38. Vasodilators 39. Drugs for Hypertension 40. Drugs for Heart Failure 41. Antidysrhythmic Drugs 42. Prophylaxis of Atherosclerotic Cardiovascular Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels 43. Drugs for Angina Pectoris 44. Anticoagulant, Antiplatelet, and Thrombolytic Drugs 45. Drugs for Deficiency Anemias UNIT X: DRUGS FOR ENDOCRINE DISORDERS 46. Drugs for Diabetes Mellitus 47. Drugs for Thyroid Disorders UNIT XI: WOMEN'S HEALTH 48. Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications 49. Birth Control UNIT XII: MEN'S HEALTH 50. Androgens 51. Drugs for Erectile Dysfunction and Benign Prostatic Hyperplasia UNIT XIII: ANTI-INFLAMMATORY, ANTIALLERGIC, AND IMMUNOLOGIC DRUGS 52. Review of the Immune System 53. Childhood Immunization 54. Antihistamines 55. Cyclooxygenase Inhibitors: Nonsteroidal Anti-inflammatory Drugs and Acetaminophen 56. Glucocorticoids in Nonendocrine Disorders UNIT XIV: DRUGS FOR BONE AND JOINT DISORDERS 57. Drug Therapy of Rheumatoid Arthritis 58. Drug Therapy of Gout 59. Drugs Affecting Calcium Levels and Bone Mineralization UNIT XV: RESPIRATORY TRACT DRUGS 60. Drugs for Asthma and Chronic Obstructive Pulmonary Disease 61. Drugs for Allergic Rhinitis, Cough, and Colds UNIT XVI: GASTROINTESTINAL DRUGS 62. Drugs for Peptic Ulcer Disease 63. Laxatives 64. Other Gastrointestinal Drugs UNIT XVII: NUTRITION AND COMPLIMENTARY THERAPIES 65. Vitamins 66. Drugs for Weight Loss 67. Complementary and Alternative Therapies UNIT XIII: THERAPY OF INFECTIOUS AND PARASITIC DISEASES 68. Basic Principles of Antimicrobial Therapy 69. Drugs That Weaken the Bacterial Cell Wall I: Penicillins 70. Drugs That Weaken the Bacterial Cell Wall II: Other Drugs 71. Bacteriostatic Inhibitors of Protein Synthesis 72. Aminoglycosides: Bactericidal Inhibitors of Protein Synthesis 73. Sulfonamides and Trimethoprim 74. Drug Therapy of Urinary Tract Infections 75. Antimycobacterial Agents 76. Miscellaneous Antibacterial Drugs 77. Antifungal Agents 78. Antiviral Agents I: Drugs for Non-HIV Viral Infections 79. Antiviral Agents II: Drugs for HIV Infection and Related Opportunistic Infections 80. Drug Therapy of Sexually Transmitted Diseases 81. Anthelmintics, Antiprotozoal Drugs, and Ectoparasiticides UNIT XIX: CANCER CHEMOTHERAPY 82. Supportive Care of Patients Receiving Anticancer Drugs 83. Drugs for Cancer Pain UNIT XX: Drugs for Eyes, Ears, and Skin 84. Drugs for the Eye 85. Drugs for the Skin 86. Drugs for the Ear UNIT XXI: DRUG THERAPY IN ACUTE CARE 87. Agents Affecting the Volume and Ion Content of Body Fluids 88. Management of ST-Elevation Myocardial Infarction 89. Additional Acute Care Drugs Rosenthal: Lehne's Pharmacotherapeutics for Advanced Practice Providers, 1st Ed. Chapter 1: Prescriptive Authority Test Bank Multiple Choice 1. An APRN works in a urology clinic under the supervision of a physician who does not restrict the types of medications the APRN is allowed to prescribe. State law does not require the APRN to practice under physician supervision. How would the APRN’s prescriptive authority be described? a. Full authority b. Independent c. Without limitation d. Limited authority ANS: B The APRN has independent prescriptive authority because the regulating body does not require that the APRN work under physician supervision. Full prescriptive authority gives the provider the right to prescribe independently and without limitation. Limited authority places restrictions on the types of drugs that can be prescribed.DIF: Cognitive Level: ComprehensionREF: p. 1TOP: Nursing Process: I MSC: NCLEX Client Needs Category: Physiologic Integrity: Pharmacologic and Parenteral Therapies 2. Which factors increase the need for APRNs to have full prescriptive authority? a. More patients will have access to health care. b. Enrollment in medical schools is predicted to decrease. c. Physician’s assistants are being utilized less often. d. APRN education is more complex than education for physicians. ANS: A Implementation of the Affordable Care Act has increased the number of individuals with health care coverage, and thus the number who have access to health care services. The increase in the number of patients creates the need for more providers with prescriptive authority. APRNs can fill this practice gap.DIF: Cognitive Level: ComprehensionREF: p. 2TOP: Nursing Process: Implementation MSC: NCLEX Client Needs Category: Physiologic Integrity: Pharmacologic and Parenteral Therapies 3. Which factors could be attributed to limited prescriptive authority for APRNs? Select all that apply. 2 a. Inaccessibility of patient care b. Higher health care costs c. Higher quality medical treatment d. Improved collaborative care e. Enhanced health literacy ANS: A , B Limiting prescriptive authority for APRNs can create barriers to quality, affordable, and accessible patient care. It may also lead to poor collaboration among providers and higher health care costs. It would not directly impact patient’s health literacy.DIF: Cognitive Level: ComprehensionREF: p. 2TOP: Nursing Process: Implementation MSC: NCLEX Client Needs Category: Physiologic Integrity: Pharmacologic and Parenteral Therapies 4. Which aspects support the APRN’s provision for full prescriptive authority? Select all that apply. a. Clinical education includes prescription of medications and disease processes. b. Federal regulations support the provision of full authority for APRNs. c. National examinations provide validation of the APRN’s ability to provide safe care. d. Licensure ensures compliance with health care and safety standards. e. Limiting provision can decrease health care affordability. ANS: A , C , D APRNs are educated to practice and prescribe independently without supervision. National examinations validate the ability to provide safe and competent care. Licensure ensures compliance with standards to promote public health and safety. Limited prescriptive authority creates numerous barriers to quality, affordable, and accessible patient care.DIF: Cognitive Level: ComprehensionREF: pp. 1-2TOP: Nursing Process: Implementation MSC: NCLEX Client Needs Category: Physiologic Integrity: Pharmacologic and Parenteral Therapies 5. Which aspects support the APRN’s provision for full prescriptive authority? Select all that apply. a. Clinical education includes prescription of medications and disease processes. b. Federal regulations support the provision of full authority for APRNs. c. National examinations provide validation of the APRN’s ability to provide safe care. d. Licensure ensures compliance with health care and safety standards. ANS: A , C , D APRNs are educated to practice and prescribe independently without supervision. National examinations validate the ability to provide safe and competent care. Licensure ensures compliance with standards to promote public health and safety. Limited prescriptive authority creates numerous barriers to quality, affordable, and accessible patient care.DIF: Cognitive Level: 3 ComprehensionREF: pp. 1-2TOP: Nursing Process: Implementation MSC: NCLEX Client Needs Category: Physiologic Integrity: Pharmacologic and Parenteral Therapies 6. A family nurse practitioner practicing in Maine is hired at a practice across state lines in Virginia. Which aspect of practice may change for the APRN? a. The APRN will have less prescriptive authority in the new position. b. The APRN will have more prescriptive authority in the new position. c. The APRN will have equal prescriptive authority in the new position. d. The APRN’s authority will depend on federal regulations. ANS: A Virginia allows limited prescriptive authority, while Maine gives full authority to certified nurse practitioners. The federal government does not regulate prescriptive authority.DIF: Cognitive Level: ComprehensionREF: p. 3TOP: Nursing Process: Implementation MSC: NCLEX Client Needs Category: Physiologic Integrity: Pharmacologic and Parenteral Therapies Rosenthal: Lehne's Pharmacotherapeutics for Advanced Practice Providers, 1st Ed. Chapter 2: Rational Drug Selection and Prescription Writing Test Bank Multiple Choice